Parathyroid disorders: Difference between revisions
Line 151: | Line 151: | ||
{{Family tree/start}} | {{Family tree/start}} | ||
{{Family tree| | | | | | | | | | | | A01 | | | |}} | {{Family tree| | | | | | | | | | | | | | | | | A01 | | | | | | | | | | | | | | | |A01=Hypercalcemia}} | ||
{{Family tree| | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | |}} | |||
{{Family tree| | | | | | | | | | | | | | | | | B01 | | | | | | | | | | | | | | | |B01=Repeat (Check ionized calcium or calcium corrected for albumin)}} | |||
{{Family tree| | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | |}} | |||
{{Family tree| | | | | | | | | | | | | | | | | C01 | | | | | | | | | | | | | | | |C01=Hypercalcemia confirmed}} | |||
{{Family tree| | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | | |}} | |||
{{Family tree| | | | | | | | | | | | | | | | | D01 | | | | | | | | | | | | | | | |D01=Measure intact parathyroid hormone (PTH)}} | |||
{{Family tree| | | | | | | |,|-|-|-|-|-|-|-|-|-|+|-|-|-|-|-|-|-|.| | | | | | | | |}} | |||
{{Family tree| | | | | | | E01 | | | | | | | | E02 | | | | | | | E03 | | | | | | |E01=↑ PTH|E02=Mildly ↑ PTH|E03= ↓ PTH}} | |||
{{Family tree| | | | | | | |!| | | | | | | | | |!| | | | | | | | |!| | | | | | | |}} | |||
{{Family tree| | | | | | | F01 | | | | | | | | F02 | | | | | | | F03 | | | | | | |F01=Hyperparathyroidism|F02=Urinary calcium creatinine ratio|F03=Measure parathyroid hormone related peptide (PTHrP) and vitamin D metabolites}} | |||
{{Family tree| | | | |,|-|-|^|-|-|.| | | |,|-|-|^|-|-|.| | | | | |!| | | | | | | |}} | |||
{{Family tree| | | | G01 | | | | G02 | | G03 | | | | G04 | | | | |!| | | | | | | |G01=↑ serum phosphate<br> History of renal transplantation|G02=↓/Normal phosphate levels|G03=↑ Urinary calcium creatinine ratio|G04=↓ Urinary calcium creatinine ratio}} | |||
{{Family tree| | | | |!| | | | | |`|-|v|-|'| | | | | |!| | | | | |!| | | | | | | |}} | |||
{{Family tree| | | | H01 | | | | | | H02 | | | | | | H03 | | | | |!| | | | | | | |H01=Tertiary hyperparathyroidism|H02=Primary hyperparathyroidism|H03= Familial hypocalceuric hypercalcemia}} | |||
{{Family tree| | | | | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | |}} | |||
{{Family tree| | | | | |,|-|-|-|-|-|-|-|-|-|-|v|-|-|-|-|-|-|-|-|-|^|-|.| | | | | |}} | |||
{{Family tree| | | | | I01 | | | I02 | | | I03 | | | I04 | | | | | | I05 | | | | |I01=↑ PTHrP|I02=↑ 1,25-dihydroxy vitamin D|I03=↑ 25-hydroxy vitamin D|I04=↓ 1,25-dihydroxy vitamin D|I05=Normal PTHrP and vitamin D metabolites}} | |||
{{Family tree| | | | | |!| | | | |!| | | | |!| | | | |!| | | |,|-|-|-|+|-|-|-|.| |}} | |||
{{Family tree| | | | | J01 | | | J02 | | | J03 | | | J04 | | J05 | | J06 | | J07 |J01=Humoral hypercalcemia of malignancy|J02=Chest X-ray, ACE levels|J03=Hypervitaminosis D|J04=History of high milk intake<br>Excess calcium intake for treating osteoporosis or dyspepsia|J05=Serum protein electrophoresis|J06=Mammography|J07=Check medications}} | |||
{{Family tree| | | | | | | | | | |!| | | | | | | | | |!| | | |!| | | |!| | | |!| |}} | |||
{{Family tree| | | | | | | | | | K01 | | | | | | | | K02 | | K03 | | K04 | | |!| |K01=Bilateral hilar lympadenopathy, ↑ ACE levels|K02=Milk-alkali syndrome|K03=Multiple myeloma|K04=Breast cancer}} | |||
{{Family tree| | | | | | | | | | |!| | | | | | | | | | | | | | | | |,|-|-|-|-|^|.| | |}} | |||
{{Family tree| | | | | | | | | | L01 | | | | | | | | | | | | | | | |L02 | | | | L03 | |L01=Sarcoidosis|L02=Lithium induced hypercalcemia|L03=Thiazide diuretic induced hypercalcemia}} | |||
{{Family tree/end}} | {{Family tree/end}} | ||
A01=Hypercalcemia | |||
B01=Repeat (Check ionized calcium or Calcium corrected for albumin) | |||
C01=Hypercalcemia confirmed | |||
D01=Measure parathyroid hormone (PTH) | |||
E01=↑ parathyroid hormone|E02=Mildly ↑ parathyroid hormone|E03= ↓ parathyroid hormone | |||
F01=Hyperparathyroidism|F02=Urinary calcium creatinine ratio|F03=Measure parathyroid hormone related peptide (PTHrP) and vitamin D metabolites | |||
G01=↑ serum phosphate<br> History of renal transplantation|G02=↓/Normal phosphate levels|G03=↑ Urinary calcium creatinine ratio|G04=↓ Urinary calcium creatinine ratio | |||
H01=Tertiary hyperparathyroidism|H02=Primary hyperparathyroidism|H03= Familial hypocalceuric hypercalcemia| | |||
I01=↑ PTHrP|I02=↑ 1,25-dihydroxy vitamin D|I03=↑ 25-hydroxy vitamin D|I04=↓ 1,25-dihydroxy vitamin D|I05=Normal PTHrP and vitamin D metabolites| | |||
J01=Humoral hypercalcemia of malignancy|J02=Chest X-ray, ACE levels|J03=Hypervitaminosis D|J04=History of high milk intake<br>Excess calcium intake for treating osteoporosis or dyspepsia|J05=Serum protein electrophoresis|J06=Mammography|J07=Check medications | |||
K01=Bilateral hilar lympadenopathy, ↑ ACE levels|K02=Milk-alkali syndrome|K03=Multiple myeloma|K04=Breast cancer | |||
L01=Sarcoidosis|L02=Lithium induced hypercalcemia|L03=Thiazide diuretic induced hypercalcemia |
Revision as of 16:35, 6 October 2017
Parathyroid disorders |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Usama Talib, BSc, MD [2]
Synonyms and keywords:
Overview
Classification
Parathyroid disorders | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hyperparathyroidism | Familial hypocalciuric hypercalcemia | Hypoparathyroidism | Parathyroid hormone resistance diseases | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Primary | Secondary | Tertiary | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Post-surgical | Autoimmune | Genetic defects associated | Functional | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Pseudohypoparathyroidism | Acrodysostosis | Blomstrand chondrodysplasia | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Pseudohypoparathyroidism type 1 | Pseudohypoparathyroidism type 2 | Acrodysostosis type 1 | Acrodysostosis type 2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Type 1A | Type 1B | Type 1C | Pseudopseudohypoparathyroidism | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Diagnosis
Disorder | Laboratory findings | ||||
---|---|---|---|---|---|
Parathyroid hormone | Serum calcium | Serum phosphate | Other findings | ||
Hyperparathyroidism | Primary hyperparathyroidism | ↑ | ↑ | ↓/Normal |
|
Secondary hyperparathyroidism | ↑ | ↓/Normal | ↑ | -- | |
Tertiary hyperparathyroidism | ↑ | ↑ | ↑ | -- | |
Familial hypocalciuric hypercalcemia | Normal/↑ | Normal/↑ | -- |
| |
Hypoparathyroidism | ↓ | ↓ | ↑ |
| |
Pseudohypoparathyroidism | Pseudohypoparathyroidism type 1A | ↑ | ↓ | ↑ | |
Pseudohypoparathyroidism type 1B | ↑ | ↓ | ↑ | ||
Pseudohypoparathyroidism type 1C | ↑ | ↓ | ↑ | ||
Pseudopseudohypoparathyroidism | ↑ | ↓ | ↑ |
| |
Pseudohypoparathyroidism type 2 | Normal | Normal | Normal | -- | |
Acrodysostosis | Acrodysostosis type 1 | ↑ | ↓ | ↑ |
|
Acrodysostosis type 2 | ↑ | ↓ | ↑ |
| |
Blomstrand chondrodysplasia | ↑ | ↓ | ↑ |
Differentiating Parathyroid Disorders
- Parathyroid disorders usually cause an symptoms due to derangement in serum calcium. So, parathyroid disorders are differentiated within themselves and others on the basis of serum calcium levels.
Hypercalcemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repeat (Check ionized calcium or calcium corrected for albumin) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hypercalcemia confirmed | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Measure intact parathyroid hormone (PTH) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
↑ PTH | Mildly ↑ PTH | ↓ PTH | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hyperparathyroidism | Urinary calcium creatinine ratio | Measure parathyroid hormone related peptide (PTHrP) and vitamin D metabolites | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
↑ serum phosphate History of renal transplantation | ↓/Normal phosphate levels | ↑ Urinary calcium creatinine ratio | ↓ Urinary calcium creatinine ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tertiary hyperparathyroidism | Primary hyperparathyroidism | Familial hypocalceuric hypercalcemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
↑ PTHrP | ↑ 1,25-dihydroxy vitamin D | ↑ 25-hydroxy vitamin D | ↓ 1,25-dihydroxy vitamin D | Normal PTHrP and vitamin D metabolites | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Humoral hypercalcemia of malignancy | Chest X-ray, ACE levels | Hypervitaminosis D | History of high milk intake Excess calcium intake for treating osteoporosis or dyspepsia | Serum protein electrophoresis | Mammography | Check medications | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Bilateral hilar lympadenopathy, ↑ ACE levels | Milk-alkali syndrome | Multiple myeloma | Breast cancer | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sarcoidosis | Lithium induced hypercalcemia | Thiazide diuretic induced hypercalcemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A01=Hypercalcemia
B01=Repeat (Check ionized calcium or Calcium corrected for albumin)
C01=Hypercalcemia confirmed
D01=Measure parathyroid hormone (PTH)
E01=↑ parathyroid hormone|E02=Mildly ↑ parathyroid hormone|E03= ↓ parathyroid hormone
F01=Hyperparathyroidism|F02=Urinary calcium creatinine ratio|F03=Measure parathyroid hormone related peptide (PTHrP) and vitamin D metabolites
G01=↑ serum phosphate
History of renal transplantation|G02=↓/Normal phosphate levels|G03=↑ Urinary calcium creatinine ratio|G04=↓ Urinary calcium creatinine ratio
H01=Tertiary hyperparathyroidism|H02=Primary hyperparathyroidism|H03= Familial hypocalceuric hypercalcemia|
I01=↑ PTHrP|I02=↑ 1,25-dihydroxy vitamin D|I03=↑ 25-hydroxy vitamin D|I04=↓ 1,25-dihydroxy vitamin D|I05=Normal PTHrP and vitamin D metabolites|
J01=Humoral hypercalcemia of malignancy|J02=Chest X-ray, ACE levels|J03=Hypervitaminosis D|J04=History of high milk intake
Excess calcium intake for treating osteoporosis or dyspepsia|J05=Serum protein electrophoresis|J06=Mammography|J07=Check medications
K01=Bilateral hilar lympadenopathy, ↑ ACE levels|K02=Milk-alkali syndrome|K03=Multiple myeloma|K04=Breast cancer
L01=Sarcoidosis|L02=Lithium induced hypercalcemia|L03=Thiazide diuretic induced hypercalcemia